Skip to content
Open access

Mutations in SARS-CoV-2 Nsp1 are critical determinants of viral pathogenicity in mice

Aug 2026 · bioRxiv · 0 citations · 3 references
Biology

TL;DR

The reduced pathogenicity of rSARS-CoV-2 Nsp1 mutants highlights the potential for targeting Nsp1 for rational design of viral inhibitors and development of live-attenuated vaccine strategies as effective prophylactic and therapeutic treatments to combat SARS-CoV-2 and possibly other CoV infections.

Read PDF

Similar papers

Review Open access Sep 2026

SARS-CoV-2 Drug-Resistant Mutations in Non-Structural Proteins

Evaluating the drug resistance mechanisms of multiple SARS-CoV-2 non-structural proteins, including the main protease and the RNA-dependent RNA polymerase, as well as PLPro, EndoU, and Mac1, which contribute to viral replication and counter host innate immune responses are discussed.

M. Shaw, A. Fehr · 0 citations
#protein folding Open access Aug 2026

Scarless SARS-CoV-2 Genome Engineering and Variant Analysis

A genome engineering technology is used to change a single amino acid in the viruses’ main protease enzyme to match that of circulating Omicron isolates to demonstrate antiviral efficacy of approved drugs and uncover mutants with reduced drug sensitivity.

Agnieszka Dabrowska, Ashley Cuell, Rahul Basu et al. · 0 citations
Open access Sep 2026

Variant-specific nucleocapsid mutations shape host innate immune trajectories during SARS- CoV-2 infection

It is found that the mutations induce distinct transcriptional and translational alterations: rN-Alpha drives a stealth-like infection characterized by sustained translation efficiency and specific evasion of the 2’-5’-oligoadenylate synthetase (OAS) innate immune sensor, whereas rN-Delta and rN-BA trigger a highly ele...

J. Berger, Jonas Schröder, Timothy K. Soh et al. · 0 citations
Open access Sep 2026

Transmission of mutated SARS-CoV-2 variants is favored by relatively prolonged infections due to delayed immunity

SARS-CoV-2 evolution enhanced viral fitness and immune evasion, extending the COVID-19 pandemic and resulting in millions of excess deaths. Viral diversity is generated within infected individuals, yet the timing and interplay of viral and immunological forces that drive transmissible evolution are incompletely underst...

Katherine Owens, Pierce E. Radecki, S. Tempia et al. · 0 citations
Open access Aug 2026

SARS-CoV-2 3CLpro inhibits the replication of influenza viruses through the cleavage of NP and PA

The data uncover a direct, enzyme-based mechanism by which SARS-CoV-2 can suppress influenza virus replication during coinfection and provide a molecular explanation for the sharp, global decline in influenza activity observed during the COVID-19 pandemic.

Liubing Du, Xiaoyu Cai, Zi-Tao Peng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.